Characterisation of circulating chromogranin A in human cancer patients
1996

Study of Chromogranin A in Cancer Patients

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): A Corti, A Gasparri, F-X Chen, M Pelagi, A Brandazza, A Sidoli, AG Siccardi

Primary Institution: San Raffaele H Scientific Institute, University of Milan

Hypothesis

Different conformations and shapes contribute to the heterogeneity of circulating chromogranin A.

Conclusion

Circulating chromogranin A in phaeochromocytoma patients consists of at least three forms with different hydrodynamic properties and immunoreactivity.

Supporting Evidence

  • Chromogranin A was found to circulate in at least three different antigenic forms.
  • The proportion of each form varied among patients.
  • Different assays detected different forms of chromogranin A with varying immunoreactivity.

Takeaway

This study looked at a protein called chromogranin A in cancer patients and found that it comes in different shapes, which can help doctors understand more about the disease.

Methodology

The study used size exclusion chromatography, Western blot analysis, and various immunoassays to characterize chromogranin A.

Limitations

The study does not address the specific clinical implications of the different forms of chromogranin A.

Participant Demographics

Included phaeochromocytoma patients and healthy controls.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication